Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11185499
Multilayer thin film drug delivery device and methods of making and using the same
granted -
US 11185562
Compositions and methods for inhibition of pathogenic bacterial growth
granted -
US 11185554
Method of use of eritoran as a TLR4 antagonist for treatment of ebola and Marburg disease
granted -
US 11185550
Pharmaceutical compositions comprising meloxicam
granted -
US 11185551
Peripherally-restricted dual-acting kappa and delta opioid agonist for analgesia in pain states involving the inflammatory response
granted -
US 11186849
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 11185506
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 11186822
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted -
US 11179486
Wet wiper
granted -
US 11181536
Methods for monitoring treatment of chronic liver disease
granted -
US 11180751
CRISPR enzymes and systems
granted -
US 11180765
Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety
granted -
US 11180553
Chimeric antigen receptor
granted -
US 11180540
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11180518
Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma
granted -
US 11180562
Method of treating or delaying progression of an epidermal growth factor receptor (EGFR)-related disorder by administering activatable EGFR-binding antibodies
granted -
US 11180531
Bicyclic peptide ligands specific for Nectin-4
granted -
US 11180529
Alpha-v beta-6 integrin ligands and uses thereof
granted -
US 11180499
Phosphodiesterase inhibitors
granted -
US 11180498
Substituted pyrrolo[2,3-b]pyridines, pyrazolo[3,4-d]pyrimidines and [1,2,3]triazolo[4,5-b]pyridines as potent antivirals
granted -
US 11180492
Anti-parasitic compounds and uses thereof
granted -
US 11180494
Substituted amino acids as integrin inhibitors
granted -
US 11180484
Pyrazole derivatives as plasma kallikrein inhibitors
granted -
US 11180493
SGC stimulators
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.